Related references
Note: Only part of the references are listed.5,6-Dihydro-5-aza-2′-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors
Jonathan M. Rawson et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Effect of Ribonucleotides Embedded in a DNA Template on HIV-1 Reverse Transcription Kinetics and Fidelity
Waaqo Daddacha et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Back to the future: revisiting HIV-1 lethal mutagenesis
Michael J. Dapp et al.
TRENDS IN MICROBIOLOGY (2013)
Advances in antiretroviral therapy
Jose R. Arribas et al.
CURRENT OPINION IN HIV AND AIDS (2013)
New therapeutic landscape of NNRTIs for treatment of HIV: a look at recent data
Dushyantha Jayaweera et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
Frequent Incorporation of Ribonucleotides during HIV-1 Reverse Transcription and Their Attenuated Repair in Macrophages
Edward M. Kennedy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Nadine Laguette et al.
NATURE (2011)
Ribonucleoside Triphosphates as Substrate of Human Immunodeficiency Virus Type 1 Reverse Transcriptase in Human Macrophages
Edward M. Kennedy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
5-Azacytidine Can Induce Lethal Mutagenesis in Human Immunodeficiency Virus Type 1
Michael J. Dapp et al.
JOURNAL OF VIROLOGY (2009)
Effect of Ribavirin on the Mutation Rate and Spectrum of Hepatitis C Virus In Vivo
Jose M. Cuevas et al.
JOURNAL OF VIROLOGY (2009)
Lethal mutagenesis of picornaviruses with n-6-modified purine nucleoside analogues
Jason D. Graci et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Pyrophosphorolytic excision of nonobligate chain terminators by hepatitis C virus NS5B polymerase
Jerome Deval et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
2′-C-Methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus
Goris Nesya et al.
ANTIVIRAL RESEARCH (2007)
Design, synthesis, and antiviral activity of 2′-deoxy-2′-fluoro-2′-C-methylcytidine, a potent inhibitor of hepatitis C virus replication
JL Clark et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
KP-1212/1461, a nucleoside designed for the treatment of HIV by viral mutagenesis
KS Harris et al.
ANTIVIRAL RESEARCH (2005)
Opioids and the progression of simian aids
RY Chuang et al.
FRONTIERS IN BIOSCIENCE (2005)
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
AM Sheehy et al.
NATURE (2002)
Multiple amino acid substitutions allow DNA polymerases to synthesize RNA
PH Patel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Coupling ribose selection to fidelity of DNA synthesis -: The role of Tyr-115 of human immunodeficiency virus type 1 reverse transcriptase
CE Cases-González et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Potentiation of the anti-HIV activity of zalcitabine and lamivudine by a CTP synthase inhibitor, 3-deazauridine
WY Gao et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2000)
Response of foot-and-mouth disease virus to increased mutagenesis: Influence of viral load and fitness in loss of infectivity
S Sierra et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
